Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.93 USD
−81.41 M USD
0.00 USD
28.55 M
About Leap Therapeutics, Inc.
Sector
Industry
CEO
Doug E. Onsi
Website
Headquarters
Cambridge
Founded
2011
FIGI
BBG00DQ929W6
Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of LPTX is 2.92 USD — it has increased by 10.19% in the past 24 hours. Watch Leap Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Leap Therapeutics, Inc. stocks are traded under the ticker LPTX.
LPTX stock has risen by 8.15% compared to the previous week, the month change is a −20.65% fall, over the last year Leap Therapeutics, Inc. has showed a 13.18% increase.
We've gathered analysts' opinions on Leap Therapeutics, Inc. future price: according to them, LPTX price has a max estimate of 16.00 USD and a min estimate of 5.50 USD. Watch LPTX chart and read a more detailed Leap Therapeutics, Inc. stock forecast: see what analysts think of Leap Therapeutics, Inc. and suggest that you do with its stocks.
LPTX reached its all-time high on Apr 12, 2018 with the price of 102.50 USD, and its all-time low was 1.24 USD and was reached on Oct 2, 2023. View more price dynamics on LPTX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LPTX stock is 18.15% volatile and has beta coefficient of 0.07. Track Leap Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Leap Therapeutics, Inc. there?
Today Leap Therapeutics, Inc. has the market capitalization of 111.89 M, it has decreased by −5.84% over the last week.
Yes, you can track Leap Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Leap Therapeutics, Inc. is going to release the next earnings report on Mar 24, 2025. Keep track of upcoming events with our Earnings Calendar.
LPTX earnings for the last quarter are −0.44 USD per share, whereas the estimation was −0.49 USD resulting in a 10.93% surprise. The estimated earnings for the next quarter are −0.40 USD per share. See more details about Leap Therapeutics, Inc. earnings.
Leap Therapeutics, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
LPTX net income for the last quarter is −18.18 M USD, while the quarter before that showed −20.13 M USD of net income which accounts for 9.70% change. Track more Leap Therapeutics, Inc. financial stats to get the full picture.
No, LPTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 28, 2024, the company has 54.00 employees. See our rating of the largest employees — is Leap Therapeutics, Inc. on this list?
Like other stocks, LPTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Leap Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Leap Therapeutics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Leap Therapeutics, Inc. stock shows the sell signal. See more of Leap Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.